568 participants
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-03-14
- Start Date:
- 2007-01-31
- Completion:
- 2014-04-30
Conditions
- Neoplasm Metastasis
- Colorectal Cancer
Interventions
- DRUG
No Results Yet